Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-02

Clinical Trial Update: Modified Conditioning Regimen for CML-BP [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating a modified conditioning regimen for chronic myeloid leukemia in blast phase patients undergoing hematopoietic stem cell t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: CML,Blast Phase, HSCT | Phase 2 | Status: NOT_YET_RECRUITING